Endometrial cancer (EC) is one of the most common gynecologic cancers and its incidence
is rising globally. Although advanced EC has a poor prognosis; diagnosing EC at an earlier …

Endometrial cancer is the most common gynaecological malignancy in high income
countries and its incidence is rising. Whilst most women with endometrial cancer are …

Endometrial cancer (EC) is the most common gynaecologic malignancy in the developed
countries. Recent evidence suggests that histopathological subtyping together with …

As the use of next‐generation sequencing (NGS) for plasma cell‐free DNA (cfDNA)
continues to expand in clinical settings, accurate identification of circulating tumor DNA …

One emerging problem for onco-gynecologists is the incidence of premenopausal patients
under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to …

Purpose: We sought to determine whether sequencing analysis of circulating cell-free DNA
(cfDNA) in patients with prospectively accrued endometrial cancer captures the mutational …

Ovarian cancer (OC) is the most lethal cancer of all gynecological malignancies, while
endometrial cancer (EC) is the most common one. Current strategies for OC/EC diagnosis …

Background The incidence of endometrial cancer is rising, and current diagnostics often
require invasive biopsy procedures. Urine may offer an alternative sample type, which is …

Ovarian cancer is one of the most common gynecologic cancers that has the highest
mortality rate. Endometrioid ovarian cancer, a distinct subtype of epithelial ovarian cancer, is …

The analysis of mismatch repair proteins in solid tissue is the standard of care (SoC) for the
microsatellite instability (MSI) characterization in endometrial cancer (EC). Uterine aspirates …